Article in Platelets, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Marcin A SowaLeon H. Charney Division of Cardiology, Department of Medicine, Cardiovascular Research Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-0038-0122
Michael TuenNYU Langone Vaccine Center, and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0009-0004-3421-9323
Florencia SchlampLeon H. Charney Division of Cardiology, Department of Medicine, Cardiovascular Research Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-3319-6778
Yuhe XiaLeon H. Charney Division of Cardiology, Department of Medicine, Cardiovascular Research Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-5723-7648
Marie I SamanovicNYU Langone Vaccine Center, and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-6987-2232
Mark J MulliganNYU Langone Vaccine Center, and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-7262-9746
Tessa J BarrettLeon H. Charney Division of Cardiology, Department of Medicine, Cardiovascular Research Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0003-0751-1578
Funding
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) - DMID 21-0012UM1AI148574 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Angelica Cifuentes Kottkamp, Anoma Nellore · 2020 to 2026
$23.9M
CD37 as a Regulator of Platelet Patho(Physiological) ResponsesR01HL167917 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Tessa Barrett · 2023 to 2026
SARS-CoV-2 infection is associated with platelet hyperreactivity and increased rates of arterial and venous thrombosis. SARS-CoV-2 mutations have resulted in several variants with differences in transmissibility, infectivity, and patient outcomes. This study investigates the effects of the ancestral strain of SARS-CoV-2 (WA1) and two variants of concern, Delta and Omicron, on the human megakaryocyte (MK) phenotype and transcriptome. Human CD34
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Megakaryocyte phenotyping in response to SARS-CoV-2 variants. · full record | OpenQuestion